Related Experiment Video
Updated: Jul 9, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
J Pomerantz1, N Schreiber-Agus, N J Liégeois
1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Abstract:
The INK4a gene encodes two distinct growth inhibitors--the cyclin-dependent kinase inhibitor p16Ink4a, which is a component of the Rb pathway, and the tumor suppressor p19Arf, which has been functionally linked to p53. Here we show that p19Arf potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19Arf and MDM2 physically interact and that p19Rrf blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19Arf functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.
Insights
The INK4a gene
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Cycle Regulation
Background:
- The INK4a gene produces two tumor suppressors: p16Ink4a (Rb pathway) and p19Arf (p53 pathway).
- Understanding the interplay between these proteins is crucial for cancer research.
Purpose of the Study:
- To investigate the role of p19Arf in suppressing oncogenic transformation.
- To elucidate the mechanism by which p19Arf interacts with and regulates p53.
- To understand the cooperative function of p16Ink4a and p19Arf in tumor suppression.
Main Methods:
- Cell-based assays to assess oncogenic transformation.
- Experiments involving viral oncoproteins and dominant-negative mutants to neutralize p53.
- Co-immunoprecipitation to study protein interactions.
- Western blotting to analyze protein degradation and activity.
Main Results:
- p19Arf effectively suppresses oncogenic transformation in primary cells.
- p53 neutralization by viral oncoproteins abrogates p19Arf's suppressive function.
- p19Arf physically interacts with MDM2.
- p19Arf inhibits MDM2-mediated p53 degradation and silencing.
- p19Arf prevents MDM2 from neutralizing p53.
Conclusions:
- p19Arf's tumor suppressor activity is mediated by its interaction with and stabilization of p53.
- The INK4a gene's potent tumor suppressor function arises from the combined actions of p16Ink4a and p19Arf.
- These findings highlight the critical roles of the Rb and p53 pathways in controlling cell growth and preventing cancer.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

